Brand Intelligence Graph
Company Overview
About NEOK Bio
NEOK Bio is targeting neuroinflammation — the chronic activation of brain immune cells (microglia and astrocytes) — as a primary driver of neurodegeneration in Alzheimer's disease, ALS, and Parkinson's disease. The company's small molecule drug candidates modulate the NLRP3 inflammasome and related innate immune pathways in the brain, aiming to reduce the toxic inflammatory environment that kills neurons over time.
Business Model & Competitive Advantage
Founded in 2022 and emerging from stealth in 2025, NEOK Bio's scientific foundation draws from decade-long academic research linking neuroinflammation biomarkers to disease progression rates. The $80M funding will advance lead candidates into IND-enabling studies targeting a 2026 clinical trial initiation for its ALS program.
Competitive Landscape 2025–2026
Neuroinflammation as a therapeutic target has gained significant traction following the partial success of anti-amyloid antibodies (Leqembi, Kisunla) in Alzheimer's — which work partly by reducing inflammatory burden — and the identification of microglial genetic variants (TREM2, CD33) as major Alzheimer's risk factors. NEOK Bio's approach complements amyloid-targeting strategies by addressing the inflammatory component of neurodegeneration.
Key Differentiators
Emerging Innovator
NEOK Bio is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Muna Therapeutics
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare NEOK Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from NEOK Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim NEOK Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention NEOK Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →